Calamos Wealth Management LLC Vertex Pharmaceuticals Inc Transaction History

Calamos Wealth Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 26, 2021	SELL	$181.39 - $202.99 $358,426 - $401,108	-1,976 Closed	0 $0
Q2 2021 Jul 22, 2021	SELL	$187.49 - $221.1 $4.17 Million - $4.91 Million	-22,226 Reduced 91.84%	1,976 $398,000
Q1 2021 Apr 12, 2021	BUY	$207.02 - $241.31 $90,881 - $105,935	439 Added 1.85%	24,202 $5.2 Million
Q4 2020 Jan 27, 2021	BUY	$207.01 - $276.09 $235,370 - $313,914	1,137 Added 5.03%	23,763 $5.62 Million
Q3 2020 Oct 26, 2020	SELL	$255.65 - $303.1 $144,442 - $171,251	-565 Reduced 2.44%	22,626 $6.16 Million
Q2 2020 Jul 27, 2020	BUY	$225.48 - $295.8 $145,209 - $190,495	644 Added 2.86%	23,191 $6.73 Million
Q1 2020 Apr 28, 2020	BUY	$199.77 - $247.81 $4.5 Million - $5.59 Million	22,547 New	22,547 $5.37 Million

1,716

225M

1.19M

1.56M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Calamos Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Calamos Wealth Management LLC with notifications on news.